The FDA has approved Tevimbra (tislelizumab) for use in combination with chemotherapy as first-line treatment for unresectable or metastatic, PD-L1-positive ESCC.

Overall survival was statistically significantly improved in adults treated with tislelizumab/chemotherapy compared with placebo/chemotherapy. The Food and Drug ...

No head-to-head trials for second-line advanced therapies for UC had been performed, he said. So Bouguen and colleagues conducted a randomized, double-blind trial to determine whether vedolizumab ...

Today’s EASL update, poster number P02-13, presented by Dr Jeff Evans on Thursday February 20 th, confirmed encouraging efficacy with a median overall survival of 13.7 months in second- or third line ...

Learn the formula for LinkedIn engagement so your LinkedIn posts go further and your business grows. Use advanced psychology ...

After Google and Samsung, it looks like another Android phone maker could be bundling a Gemini Advanced subscription with its flagship phone.

Last Friday, when the Seahawks agreed to trade quarterback Geno Smith to the Raiders, there's no way the Seahawks didn't know that they'd be signing quarterback Sam Darnold — tampering rules be damned ...

The Lady Toppers will take on Middle Tennessee in the semi-final round of the CUSA Championship on Friday, March 14 at 8 p.m.

Laser Photonics Corporation (NASDAQ: LASE) (“LPC”), a leading global developer of industrial laser systems for cleaning and ...

CSCS will play in their third straight Final Four and Air Academy is heading back to the state championship for the first ...

It wasn’t about how the game started for Cornerstone Christian, it was about how it finished its Division VII state semifinal against South Webster on March 14.

Tislelizumab plus chemotherapy received FDA approval as a frontline therapy for individuals with unresectable or metastatic ...